MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Diagnostic journeys of people with Parkinson’s disease in Kenya, sub-Saharan Africa

N. Fothergill Misbah, K. Hampshire, S. Moffatt, J. Kwasa, J. Hooker, R. Walker (Newcastle Upon Tyne, United Kingdom)

Meeting: 2019 International Congress

Abstract Number: 711

Keywords: Parkinsonism

Session Information

Date: Monday, September 23, 2019

Session Title: Other

Session Time: 1:45pm-3:15pm

Location: Agora 2 West, Level 2

Objective: To explore the experiences of people living with Parkinson’s disease (PWPD) with regards to their diagnostic journeys among public and private hospital settings in Kenya.

Background: Research on Parkinson’s disease (PD) in Kenya (population 51.4 million), is scant [1], while knowledge about PD among the population as well as healthcare professionals is low. This qualitative study examines diagnosis, care and information provision amongst PWPD and their families in Kenya.

Method: Ethnographic methods comprising interviews and observations were applied over 9 months (March – December 2018) across urban and rural areas. Participants included PWPD (N=53), family members and caregivers (N=22), medical consultants in private and public hospitals (N=13), pharmacists (N=28), community health volunteers (N=2) and herbal doctors (N=5).

Results: Obtaining a diagnosis of PD in Kenya is challenging and far from straightforward in all settings. The number of practicing neurologists is very low (N=20), clinics are overwhelmed by neurological cases in private and government hospitals and there are no practicing PD nurse specialists. Interviews with PWPD identified that symptoms of PD are often confused with general ageing or overlooked and PWPD don’t seek medical help until their condition has progressed. As knowledge about the disease is low amongst healthcare professionals, when PWPD do seek help, they are bounced around services, misdiagnosed and some PWPD are never told their diagnosis. Information provision about PD, symptoms and progression at diagnosis is minimal and consequently PWPD have a very poor understanding about their disease.

Conclusion: Diagnostic journeys of PWPD in Kenya are difficult, within private and public settings. Kenya has limited resources to invest into healthcare as well as huge pressures from other non-communicable and communicable diseases. However, as the population ages, the incidence of PD will increase. There is a need to improve knowledge about PD among healthcare professionals and the population so the early symptoms of PD are recognised and accurately diagnosed. More structured neurology services to manage PD including integrated care involving neurologists and PD nurse specialists are also required.

References: 1. The Lancet Neurology: Neurology in sub-Saharan Africa-WHO cares? Lancet neurology. 2006, 5 (8): 637

To cite this abstract in AMA style:

N. Fothergill Misbah, K. Hampshire, S. Moffatt, J. Kwasa, J. Hooker, R. Walker. Diagnostic journeys of people with Parkinson’s disease in Kenya, sub-Saharan Africa [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/diagnostic-journeys-of-people-with-parkinsons-disease-in-kenya-sub-saharan-africa/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/diagnostic-journeys-of-people-with-parkinsons-disease-in-kenya-sub-saharan-africa/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley